Streptococcus agalactiae endophthalmitis in boston keratoprosthesis in a patient with steven-johnson syndrome
| Autor: | Donald U. Stone, Igor Kozak, Humoud Al-Otaibi, William N May, Omar Kirat, Mohammed Talea |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
medicine.medical_specialty
Visual acuity genetic structures Hand motion Ceftazidime Case Report medicine.disease_cause Streptococcus agalactiae Keratitis 03 medical and health sciences 0302 clinical medicine Endophthalmitis Ophthalmology medicine business.industry Boston Keratoprosthesis General Medicine medicine.disease eye diseases Surgery Steven–Johnson Syndrome 030221 ophthalmology & optometry Vancomycin sense organs Boston keratoprosthesis medicine.symptom business 030217 neurology & neurosurgery medicine.drug |
| Zdroj: | Middle East African Journal of Ophthalmology |
| ISSN: | 0974-9233 |
| DOI: | 10.4103/0974-9233.194095 |
| Popis: | A 25-year-old Syrian male with a previous episode of Stevens-Johnson syndrome with bilateral corneal cicatrization previously underwent surgery for Type 1 Boston Keratoprosthesis (K-Pro). Sixteen months after the K-Pro surgery, the patient presented with decreased vision to hand motion and microbial keratitis of the graft around the K-Pro with purulent discharge. Corneal scrapings were nonrevealing. B-scan in 3 days showed increased debris in the vitreous cavity and thickened retinochoroidal layer. Intravitreal tap and injections of vancomycin and ceftazidime were performed. The vitreous culture revealed β-hemolytic Streptococcus agalactiae; fungal cultures were negative. Repeat B-scan 3 days later demonstrated decreased vitreous opacity, and the patient felt more comfortable and was without pain. His visual acuity improved to 20/70, ocular findings have been stable for 9 months, and the patient continues to be monitored. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|